Conversely, the low phosphorylation of steroid receptor coactivator protein 3 (SRC-3) by DYRK3 promoted purine metabolism and hepatocellular carcinoma progression [11]. The gene discussed is DYRK3; the disease is hepatocellular carcinoma.